COMPASS Pathways plc

Stocks

CMPS

US20451W1018

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-08 EDT			After hours 20:00:00
13.96 ^USD	+7.51%		13.57	-2.83%

07-08	Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says	MT
07-07	Compass Pathways Says Second Phase 3 Trial Confirms Durable Benefit of Depression Treatment	MT

Transcript : COMPASS Pathways plc - Special Call

Published on 07/07/2026 at 10:38 am EDT - Modified on 07/08/2026 at 09:35 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presentation Operator Message
Operator (Operator)

Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Update Webinar. [Operator Instructions] As a reminder, this call is being recorded.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about COMPASS Pathways plc

07-08	Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says	MT
07-07	Compass Pathways Says Second Phase 3 Trial Confirms Durable Benefit of Depression Treatment	MT
07-07	COMPASS Pathways plc - Special Call
07-07	Compass Pathways Reports Six-Month Data from Second Phase 3 Trial of Comp360 for Treatment-Resistant Depression	CI
06-30	Healthcare Stocks Fall as Markets Rotate Back to Tech -- Healthcare Roundup	DJ
06-26	European Equities Traded in the US as American Depositary Receipts Decline Friday	MT
06-22	Definium's LSD-based depression pill delivers strong late-stage results, shares surge	RE
05-28	Compass Pathways plc Announces Appointment of Kathleen Tregoning to Board of Directors	CI
05-18	Trump's psychedelic drug order boosts investor interest with promise of faster reviews	RE
05-14	RBC Raises Price Target on COMPASS Pathways to $22 From $21, Keeps Outperform, Speculative Risk	MT
05-13	COMPASS Pathways plc Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	COMPASS Pathways plc, Q1 2026 Earnings Call, May 13, 2026
05-13	COMPASS Pathways Q1 Loss Widens	MT
05-13	Earnings Flash (CMPS) COMPASS Pathways Posts Q1 Net Loss $0.30 a Share, vs. FactSet Est of $0.43 Loss	MT
05-06	HEALTH ROUNDS-Researchers gain new insight into how psychedelics affect the brain	RE